{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:01:23Z","timestamp":1790398883832,"version":"4.1.0"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012631"],"award-info":[{"award-number":["2024A1515012631"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82322074"],"award-info":[{"award-number":["82322074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505151"],"award-info":[{"award-number":["82505151"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.addr.2026.115973","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:25:01Z","timestamp":1789665901000},"page":"115973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fibrosis: Bridging fundamental mechanisms to precision medicine via advanced therapeutics"],"prefix":"10.1016","volume":"239","author":[{"given":"Lin","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0005","first-page":"129","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines, signal Transduct","volume":"8","author":"Huang","year":"2023","journal-title":"Target. Ther."},{"issue":"7835","key":"10.1016\/j.addr.2026.115973_bb0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0020","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.molmed.2023.08.010","article-title":"Pulmonary fibrosis: from pathogenesis to clinical decision-making","volume":"29","author":"Koudstaal","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-018-0710-z","article-title":"Matrix stiffness: the conductor of organ fibrosis","volume":"20","author":"Santos","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0035","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0040","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev-physiol-022516-034356","article-title":"Mechanisms of organ injury and repair by macrophages","volume":"79","author":"Vannella","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The Myofibroblast","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"22","key":"10.1016\/j.addr.2026.115973_bb0055","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of Nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0060","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/rccm.201712-2410OC","article-title":"Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis","volume":"199","author":"Reyfman","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41418-024-01322-5","article-title":"MafG\/MYH9-LCN2 axis promotes liver fibrosis through inhibiting ferroptosis of hepatic stellate cells","volume":"31","author":"Deng","year":"2024","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40580-023-00385-3","article-title":"Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy","volume":"10","author":"Han","year":"2023","journal-title":"Nano Converg."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0075","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-024-51056-8","article-title":"Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115973_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114378","article-title":"Nintedanib-amplified effects of HSP47 siRNA on liver fibrosis therapy by inhibiting collagen secretion","volume":"388","author":"Yang","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0085","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1172\/JCI122462","article-title":"TGF-\u03b2\u2013induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis","volume":"130","author":"Dees","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2026.115973_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1423045","article-title":"Emerging roles of non-coding RNAs in fibroblast to myofibroblast transition and fibrotic diseases","volume":"15","author":"Xing","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0095","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.addr.2026.115973_bb0100","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.3390\/ijms26083550","article-title":"From skeletal muscle to myocardium: molecular mechanisms of exercise-induced Irisin regulation of cardiac fibrosis","volume":"26","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115973_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1323329","article-title":"Exercise improves cardiac fibrosis by stimulating the release of endothelial progenitor cell-derived exosomes and upregulating miR-126 expression","volume":"11","author":"Fu","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"17","key":"10.1016\/j.addr.2026.115973_bb0110","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.3390\/ijms26178394","article-title":"Fibrotic disease of the skin and lung: shared pathways, environmental drivers, and therapeutic opportunities in a changing climate","volume":"26","author":"Grafanaki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109955","article-title":"Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors","volume":"37","author":"He","year":"2021","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.addr.2026.115973_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70304","article-title":"Macrophages: subtypes, distribution, polarization, immunomodulatory functions, and therapeutics","volume":"6","author":"Peng","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.addr.2026.115973_bb0130","article-title":"Different roles of resident and non-resident macrophages in cardiac fibrosis","volume":"9","author":"Hu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.120.050682","article-title":"MicroRNA-21\u2013dependent macrophage-to-fibroblast signaling determines the cardiac response to pressure overload","volume":"143","author":"Ramanujam","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0140","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41590-025-02255-y","article-title":"Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesis","volume":"26","author":"Martin","year":"2025","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0145","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","article-title":"Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice","volume":"67","author":"Ma","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.addr.2026.115973_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1533335","article-title":"IL-33\/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential","volume":"16","author":"Sheng","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s40001-025-02755-5","article-title":"Aging-associated interleukin-11 drives the molecular mechanism and targeted therapy of idiopathic pulmonary fibrosis","volume":"30","author":"Zhou","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0160","first-page":"L6","article-title":"IL-17 in the lung: the good, the bad, and the ugly","volume":"314","author":"Gurczynski","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.addr.2026.115973_bb0165","article-title":"Shapley additive explanations based feature selection reveals CXCL14 as a key immune-related gene in predicting idiopathic pulmonary fibrosis","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1564176","article-title":"Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis","volume":"12","author":"Zheng","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","article-title":"Fibrosis: cross-organ biology and pathways to development of innovative drugs","volume":"24","author":"Rieder","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052992","article-title":"Early pulmonary fibrosis-like changes in the setting of heat exposure: DNA damage and cell senescence","volume":"25","author":"Hou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0185","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ptr.8372","article-title":"Tanshinone IIA alleviates pulmonary fibrosis by inhibiting Pyroptosis of alveolar epithelial cells through the MAPK signaling pathway","volume":"39","author":"Xu","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2026.115973_bb0190","first-page":"1","article-title":"Mesenchymal stem cells inhibit epithelial-to-mesenchymal transition by modulating the IRE1\u03b1 branch of the endoplasmic reticulum stress response","volume":"2023","author":"Luo","year":"2023","journal-title":"Stem Cells Int."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0195","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1007\/s00210-025-04076-0","article-title":"Bioinformatics-based identification of mirdametinib as a potential therapeutic target for idiopathic pulmonary fibrosis associated with endoplasmic reticulum stress","volume":"398","author":"Chen","year":"2025","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0200","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/acsnano.2c11112","article-title":"ROS-responsive Janus au\/mesoporous silica Core\/Shell nanoparticles for drug delivery and long-term CT imaging tracking of MSCs in pulmonary fibrosis treatment","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.14336\/AD.2023.0222","article-title":"TGF-\u03b2 as a master regulator of aging-associated tissue fibrosis","volume":"14","author":"Zhao","year":"2023","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biom10030487","article-title":"TGF-\u03b2 signaling","volume":"10","author":"Tzavlaki","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2026.115973_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0220","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.addr.2026.115973_bb0225","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S568106","article-title":"Inhalable TFRC-targeted extracellular vesicles delivery of siTGF-beta1 alleviates pulmonary fibrosis via dual inhibition of Ferroptosis and fibroblast activation","volume":"21","author":"Liang","year":"2026","journal-title":"Int. J. Nanomedicine"},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0230","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.202112-2824OC","article-title":"A phase IIb randomized clinical study of an anti-alpha(v)beta(6) monoclonal antibody in idiopathic pulmonary fibrosis","volume":"206","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0235","article-title":"Selective blockade of latent TGF-beta1 activation suppresses tissue fibrosis with good safety","volume":"6","author":"Kanamori","year":"2026","journal-title":"Commun. Med. (Lond.)"},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0240","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.medj.2023.12.011","article-title":"Isoform-selective TGF-beta3 inhibition for systemic sclerosis","volume":"5","author":"Sun","year":"2024","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0245","first-page":"C1015","article-title":"Role of TGF-beta\/SMAD\/YAP\/TAZ signaling in skeletal muscle fibrosis","volume":"328","author":"Gallardo","year":"2025","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.addr.2026.115973_bb0250","article-title":"Molecular mechanisms and potential new therapeutic drugs for liver fibrosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0255","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0260","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0265","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/biom14101277","article-title":"Cellular and molecular mechanisms of hypertrophy of ligamentum Flavum","volume":"14","author":"Silwal","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0270","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115973_bb0275","article-title":"Dendrobium officinale polysaccharides protected against CCl4-induced liver fibrosis by inhibiting oxidative stress and TGF-\u03b21 and Wnt\/\u03b2-catenin signaling","author":"Fan","year":"2025","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567994","article-title":"Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities","volume":"16","author":"Yao","year":"2025","journal-title":"Front. Immunol."},{"issue":"23","key":"10.1016\/j.addr.2026.115973_bb0285","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.70275","article-title":"The anti-pulmonary fibrosis code of plant anthocyanins-a multi-targeted anti-fibrotic bioactive compound by inhibiting the NLRP3 inflammasome","volume":"69","author":"Tang","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0290","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41368-024-00302-2","article-title":"Exosomal miR-17-5p derived from epithelial cells is involved in aberrant epithelium-fibroblast crosstalk and induces the development of oral submucosal fibrosis","volume":"16","author":"Xie","year":"2024","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.addr.2026.115973_bb0295","article-title":"Emerging role of long non-coding RNA MALAT1 related signaling pathways in the pathogenesis of lung disease","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0300","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.addr.2026.115973_bb0305","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41580-024-00716-0","article-title":"Fibroblast and myofibroblast activation in normal tissue repair and fibrosis","volume":"25","author":"Younesi","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0310","article-title":"Pathological microenvironment-remodeling nanoparticles to alleviate liver fibrosis: reversing hepatocytes-hepatic stellate cells malignant crosstalk","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0315","article-title":"Single cell and spatial transcriptomics define a Proinflammatory and Profibrotic niche after kidney injury","volume":"13","author":"Li","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0320","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.201508-1699ED","article-title":"Aerobic glycolysis and the Warburg effect. An unexplored realm in the search for fibrosis therapies?","volume":"192","author":"Maher","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0325","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2026.115973_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1496884","article-title":"Molecular and metabolomic characterization of hiPSC-derived cardiac fibroblasts transitioning to myofibroblasts","volume":"12","author":"Nagalingam","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0335","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1096\/fj.201901599RR","article-title":"MiR-9-5p protects from kidney fibrosis by metabolic reprogramming","volume":"34","author":"Fierro-Fernandez","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0340","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-06060-3","article-title":"Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis","volume":"23","author":"Lin","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0345","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","article-title":"Pathogenic mechanisms underlying idiopathic pulmonary fibrosis","volume":"17","author":"Moss","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.addr.2026.115973_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111572","article-title":"Hepatic stellate cell senescence in liver fibrosis: characteristics, mechanisms and perspectives","volume":"199","author":"Zhang","year":"2021","journal-title":"Mech. Ageing Dev."},{"issue":"11","key":"10.1016\/j.addr.2026.115973_bb0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41419-018-1157-x","article-title":"Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury","volume":"9","author":"Qi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0360","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.addr.2026.115973_bb0365","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.7150\/ijbs.98839","article-title":"Single-cell RNA-sequencing identifies bone marrow-derived progenitor cells as a Main source of extracellular matrix-producing cells across multiple organ-based fibrotic diseases","volume":"20","author":"Zhong","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"8057","key":"10.1016\/j.addr.2026.115973_bb0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-024-08542-2","article-title":"RUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition","volume":"640","author":"Fang","year":"2025","journal-title":"Nature"},{"issue":"8038","key":"10.1016\/j.addr.2026.115973_bb0375","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-024-08085-6","article-title":"Chromatin remodelling drives immune cell-fibroblast communication in heart failure","volume":"635","author":"Alexanian","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0380","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41413-025-00400-9","article-title":"CCN2 mediates fibroblast-macrophage interaction in knee arthrofibrosis based on single-cell RNA-seq analysis","volume":"13","author":"Li","year":"2025","journal-title":"Bone Res."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0385","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41588-025-02080-x","article-title":"Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis","volume":"57","author":"Vannan","year":"2025","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0390","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ard.2025.04.025","article-title":"Spatial multiomics decipher fibroblast-macrophage dynamics in systemic sclerosis","volume":"84","author":"Li","year":"2025","journal-title":"Ann. Rheum. Dis."},{"issue":"8064","key":"10.1016\/j.addr.2026.115973_bb0395","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41586-025-08727-3","article-title":"Histological signatures map anti-fibrotic factors in mouse and human lungs","volume":"641","author":"Guo","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0400","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"35","key":"10.1016\/j.addr.2026.115973_bb0405","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/eurheartj\/ehaf372","article-title":"Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing","volume":"46","author":"Zeng","year":"2025","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0410","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0415","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/s41467-025-57024-0","article-title":"TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity","volume":"16","author":"Cui","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0420","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/s41467-024-46017-0","article-title":"A humanized mouse model for adeno-associated viral gene therapy","volume":"15","author":"Barzi","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0425","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217199120","article-title":"Innate immune cell activation causes lung fibrosis in a humanized model of long COVID","volume":"120","author":"Cui","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.addr.2026.115973_bb0430","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41423-025-01339-x","article-title":"Gut-derived indole propionic acid alleviates liver fibrosis by targeting profibrogenic macrophages via the gut\u2013liver axis","volume":"22","author":"Luo","year":"2025","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41556-021-00809-4","article-title":"Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5(+) basal cells","volume":"24","author":"Kathiriya","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0440","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1038\/s41467-023-42171-z","article-title":"A human lung alveolus-on-a-chip model of acute radiation-induced lung injury","volume":"14","author":"Dasgupta","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115973_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01479-5","article-title":"Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis","author":"Chen","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0450","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41556-025-01697-8","article-title":"Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer","volume":"27","author":"Al-Hilal","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.addr.2026.115973_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2025.100741","article-title":"Quantitative longitudinal investigation of non-alcoholic steatohepatitis in mice by photoacoustic microscopy","volume":"44","author":"Wei","year":"2025","journal-title":"Photoacoustics"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0460","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241275","article-title":"Quantification of vascular remodeling and sinusoidal capillarization to assess liver fibrosis with photoacoustic imaging","volume":"314","author":"Li","year":"2025","journal-title":"Radiology"},{"issue":"44","key":"10.1016\/j.addr.2026.115973_bb0465","doi-asserted-by":"crossref","first-page":"24370","DOI":"10.1021\/acs.analchem.5c03517","article-title":"Dual-targeting near-infrared fluorescent probe for simultaneous mitochondrial injury assessment and fibrosis monitoring in pulmonary fibrosis","volume":"97","author":"Liu","year":"2025","journal-title":"Anal. Chem."},{"issue":"20","key":"10.1016\/j.addr.2026.115973_bb0470","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1111\/bph.17347","article-title":"Diminished nuclear-localized beta-adrenoceptor signalling activates YAP to promote kidney fibrosis in diabetic nephropathy","volume":"182","author":"Xiang","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.addr.2026.115973_bb0475","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1038\/s41591-025-03743-2","article-title":"A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial","volume":"31","author":"Xu","year":"2025","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0480","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/HEP.0000000000001360","article-title":"AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Fujiwara","year":"2026","journal-title":"Hepatology"},{"issue":"44","key":"10.1016\/j.addr.2026.115973_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202508751","article-title":"AI-assisted drug re-purposing for human liver fibrosis","volume":"12","author":"Guan","year":"2025","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/endrev\/bnad036","article-title":"Endotrophin, a key marker and driver for Fibroinflammatory disease","volume":"45","author":"Henriksen","year":"2024","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0495","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41591-024-03010-w","article-title":"Noninvasive assessment of organ-specific and shared pathways in multi-organ fibrosis using T1 mapping","volume":"30","author":"Nauffal","year":"2024","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0500","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.7150\/ijbs.92620","article-title":"Nintedanib mitigates radiation-induced pulmonary fibrosis by suppressing epithelial cell inflammatory response and inhibiting fibroblast-to-Myofibroblast transition","volume":"20","author":"Tu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0505","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/j.ymthe.2022.06.019","article-title":"P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition","volume":"30","author":"Chen","year":"2022","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0510","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/s41551-025-01423-7","article-title":"A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases","volume":"9","author":"Zheng","year":"2025","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0515","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov."},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0520","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","volume":"185","author":"Raguram","year":"2022","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0525","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.cell.2025.03.015","article-title":"Engineered nucleocytosolic vehicles for loading of programmable editors","volume":"188","author":"Geilenkeuser","year":"2025","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0530","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0535","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1038\/s41467-025-59724-z","article-title":"Vitamin D supplementation ameliorates ductular reaction, liver inflammation and fibrosis in mice by upregulating TXNIP in ductular cells","volume":"16","author":"Baek","year":"2025","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0540","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41591-025-03799-0","article-title":"Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"31","author":"Jara","year":"2025","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0545","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1016\/j.apsb.2025.07.023","article-title":"Evidence that metformin promotes fibrosis resolution via activating alveolar epithelial stem cells and FGFR2b signaling","volume":"15","author":"Lv","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"22","key":"10.1016\/j.addr.2026.115973_bb0550","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis","volume":"392","author":"Richeldi","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0555","article-title":"Tetramethylpyrazine improves the structure and function of mitochondrial-associated endoplasmic reticulum membrane and liver fibrosis","author":"Xie","year":"2025","journal-title":"J. Adv. Res."},{"issue":"50","key":"10.1016\/j.addr.2026.115973_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407661","article-title":"Modulating fibrotic mechanical microenvironment for idiopathic pulmonary fibrosis therapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0565","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40617-y","article-title":"Autocrine TGF-beta-positive feedback in profibrotic AT2-lineage cells plays a crucial role in non-inflammatory lung fibrogenesis","volume":"14","author":"Enomoto","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0570","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0575","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1038\/s41467-024-54174-5","article-title":"Mechanics-activated fibroblasts promote pulmonary group 2 innate lymphoid cell plasticity propelling silicosis progression","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0580","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/HEP.0000000000000350","article-title":"Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis","volume":"78","author":"Raabe","year":"2023","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.addr.2026.115973_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202519892","article-title":"Inactivation Rap2a in endothelial cell prevents pulmonary fibrosis by regulating immune microenvironment through MAP4K4-VCAM1 signaling","volume":"13","author":"Zheng","year":"2026","journal-title":"Adv. Sci."},{"issue":"46","key":"10.1016\/j.addr.2026.115973_bb0590","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady0952","article-title":"Structure-guided design of nucleosome-inspired nanoparticles for overcoming pulmonary barriers in fibrotic lung gene therapy","volume":"11","author":"Kong","year":"2025","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0595","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acsnano.4c15130","article-title":"Inhalable siRNA targeting IL-11 nanoparticles significantly inhibit bleomycin-induced pulmonary fibrosis","volume":"19","author":"Dong","year":"2025","journal-title":"ACS Nano"},{"issue":"26","key":"10.1016\/j.addr.2026.115973_bb0600","doi-asserted-by":"crossref","first-page":"23876","DOI":"10.1021\/acsnano.5c05144","article-title":"Oral Administration of a Tetrahedral Framework DNA-based Nanoshot attenuates liver fibrosis via targeting Galectin-3","volume":"19","author":"Liu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115973_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122887","article-title":"ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis","volume":"314","author":"Yang","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0610","doi-asserted-by":"crossref","first-page":"8428","DOI":"10.1038\/s41467-024-52722-7","article-title":"Ternary inulin hydrogel with long-term intestinal retention for simultaneously reversing IBD and its fibrotic complication","volume":"15","author":"Cao","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0615","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.apsb.2020.10.016","article-title":"An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis","volume":"11","author":"Qin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2026.115973_bb0620","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2023.03.060","article-title":"ROS-responsive microneedles loaded with integrin \u03b1v\u03b26-blocking antibodies for the treatment of pulmonary fibrosis","volume":"360","author":"Ding","year":"2023","journal-title":"J. Control. Release."},{"issue":"31","key":"10.1016\/j.addr.2026.115973_bb0625","article-title":"Smart microneedle arrays integrating cell-free therapy and Nanocatalysis to treat liver fibrosis","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.addr.2026.115973_bb0630","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jconrel.2024.01.032","article-title":"Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling","volume":"366","author":"Han","year":"2024","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.addr.2026.115973_bb0635","doi-asserted-by":"crossref","first-page":"eadv9571","DOI":"10.1126\/sciadv.adv9571","article-title":"Inhalable myofibroblast targeting nanoparticles for synergistic treatment of pulmonary fibrosis","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0640","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1007\/s12274-024-6747-6","article-title":"LPA(1) antagonist-derived LNPs deliver A20 mRNA and promote anti-fibrotic activities","volume":"17","author":"Yan","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2026.115973_bb0645","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jcis.2023.01.007","article-title":"Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment","volume":"636","author":"Wang","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2026.115973_bb0650","article-title":"aHSCs-targeted bimetallic nanozymes and luteolin-loaded liposomes: synergistic reversal of liver fibrosis via antioxidant, cellular senescence, and cellular apoptotic mechanisms","volume":"34","author":"Sun","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0655","article-title":"Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis","volume":"14","author":"Han","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115973_bb0660","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","article-title":"Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis","volume":"76","author":"Kumar","year":"2016","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.addr.2026.115973_bb0665","article-title":"Inflammation-responsive cell membrane-camouflaged nanoparticles against liver fibrosis via regulating endoplasmic reticulum stress and oxidative stress","volume":"36","author":"Bai","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2026.115973_bb0670","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2021.11.033","article-title":"Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme","volume":"341","author":"Lu","year":"2022","journal-title":"J. Control. Release"},{"issue":"30","key":"10.1016\/j.addr.2026.115973_bb0675","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1016\/j.biomaterials.2010.07.008","article-title":"An anti-ROS\/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials"},{"issue":"39","key":"10.1016\/j.addr.2026.115973_bb0680","doi-asserted-by":"crossref","first-page":"34575","DOI":"10.1021\/acsnano.5c06003","article-title":"Hydrogel loaded with Aminoethyl Anisamide-modified exosomes attenuates hepatic fibrosis by targeting activated hepatic stellate cells","volume":"19","author":"Sun","year":"2025","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0685","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.apsb.2025.08.017","article-title":"RDYH58 functional exosomes targeting myofibroblasts loaded with siFKBP10 for inhibition of collagen biosynthesis and secretion of IPF","volume":"15","author":"Yuan","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0690","article-title":"Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis","volume":"20","author":"Kim","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0695","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thoraxjnl-2020-215962","article-title":"Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes","volume":"76","author":"Sato","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.addr.2026.115973_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1009139","article-title":"Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice","volume":"9","author":"Gong","year":"2022","journal-title":"Front. Nutr."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70204","article-title":"Cardiac Myofibroblast-derived small extracellular vesicles moderate fibrotic responses via piRNA-62788\/PIWIL2-mediated SRF silencing","volume":"14","author":"Li","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0710","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12124","article-title":"Human bronchial epithelial cell-derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF-beta-WNT crosstalk","volume":"10","author":"Kadota","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.addr.2026.115973_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107277","article-title":"Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming","volume":"206","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0720","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","article-title":"Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis","volume":"76","author":"Qing","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0725","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-025-56223-z","article-title":"High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0730","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-022-29186-8","article-title":"Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115973_bb0735","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s42003-019-0337-2","article-title":"Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis","volume":"2","author":"Marchetti","year":"2019","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0740","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12951-022-01435-4","article-title":"ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"10.1016\/j.addr.2026.115973_bb0745","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0750","article-title":"Nanodrug with ROS and pH dual-sensitivity ameliorates liver fibrosis via multicellular regulation","volume":"7","author":"Lin","year":"2020","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.addr.2026.115973_bb0755","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jconrel.2022.12.059","article-title":"Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis","volume":"354","author":"Lee","year":"2023","journal-title":"J. Control. Release"},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0760","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500101","article-title":"Tissue-microenvironment-responsive self-assembling peptide nanoshells boost pirfenidone efficacy in the treatment of liver fibrosis","volume":"14","author":"Li","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115973_bb0765","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2022.08.065","article-title":"Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy","volume":"152","author":"Zhou","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115973_bb0770","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.actbio.2023.06.024","article-title":"A fibroblastic foci-targeting and hypoxia-cleavable delivery system of pirfenidone for the treatment of idiopathic pulmonary fibrosis","volume":"167","author":"Zhao","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115973_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202512872","article-title":"Collagenase-coated polymeric drug\/siRNA nanoparticles overcome ECM and regulate metabolic reprogramming of fibroblasts for alleviating pulmonary fibrosis","author":"Cheng","year":"2026","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.102902","article-title":"Time- and spatially resolved LNA delivery via thermally controlled SPION technology","volume":"37","author":"Kenneweg","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0785","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1021\/acsnano.1c00988","article-title":"Treatment of hepatic fibrosis in mice based on targeted Plasmonic hyperthermia","volume":"15","author":"Ribera","year":"2021","journal-title":"ACS Nano"},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0790","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202500196","article-title":"Ultrasound-mediated biomimetic microbubbles effectively reverse LSECs capillarization and exert antiplatelet therapy in liver fibrosis","volume":"14","author":"Deng","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0795","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1021\/acsabm.5c01317","article-title":"Nitric oxide-loaded Nanobubbles for ultrasound-activated therapy of renal fibrosis","volume":"8","author":"Zhang","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.addr.2026.115973_bb0800","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2147\/IJN.S235518","article-title":"A peptide-functionalized magnetic nanoplatform-loaded melatonin for targeted amelioration of fibrosis in pressure overload-induced cardiac hypertrophy","volume":"15","author":"Zhao","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"26","key":"10.1016\/j.addr.2026.115973_bb0805","doi-asserted-by":"crossref","first-page":"33021","DOI":"10.1021\/acsami.4c04361","article-title":"Aggregation-induced emission CN-based nanoparticles to alleviate hypoxic liver fibrosis via triggering HSC Ferroptosis and enhancing photodynamic therapy","volume":"16","author":"Liu","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2026.115973_bb0810","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-932-2","article-title":"Spatial multi-omics guides ASCT2-targeted delivery of glycolysis inhibitor for cervical cancer suppression and chemoresistance reversal","author":"Li","year":"2025","journal-title":"J. Adv. Res."},{"issue":"32","key":"10.1016\/j.addr.2026.115973_bb0815","doi-asserted-by":"crossref","first-page":"eadl5473","DOI":"10.1126\/sciadv.adl5473","article-title":"Spatial transcriptomic characterization of pathologic niches in IPF","volume":"10","author":"Mayr","year":"2024","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0820","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10556","article-title":"Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety","volume":"8","author":"Kim","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.addr.2026.115973_bb0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123611","article-title":"Organoid-driven nanomedicine platform development","volume":"325","author":"Wang","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115973_bb0830","article-title":"Synergistic innovation in organ-on-a-chip and organoid technologies: reshaping the future of disease modeling, drug development and precision medicine","author":"Li","year":"2025","journal-title":"Protein Cell"},{"key":"10.1016\/j.addr.2026.115973_bb0835","article-title":"Engineering liver organoids-on-a-chip","volume":"4","author":"Zhu","year":"2025","journal-title":"Lab. Chip Technol."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0840","article-title":"Organs-on-chips in drug development: engineering foundations, artificial intelligence, and clinical translation","volume":"16","author":"Roy","year":"2026","journal-title":"Biosensors (Basel)"},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0845","article-title":"Biological barrier models-on-chips: a novel tool for disease research and drug discovery","volume":"15","author":"Caragnano","year":"2025","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/j.addr.2026.115973_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115878","article-title":"DNA-based nanostructures: advancing drug delivery and disease therapy","volume":"234","author":"Liu","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"39","key":"10.1016\/j.addr.2026.115973_bb0855","doi-asserted-by":"crossref","first-page":"eadp9071","DOI":"10.1126\/sciadv.adp9071","article-title":"An \"AND\" logic gate-based supramolecular therapeutic nanoplatform for combatting drug-resistant non-small cell lung cancer","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2026.115973_bb0860","article-title":"Logic-gated, triple-responsive DNAzyme nanoplatform for precise hepatocellular carcinoma treatment","author":"Wan","year":"2025","journal-title":"Chin. Chem. Lett."},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0865","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41565-026-02130-3","article-title":"AND logic nanoparticle for precision immunotherapy of metastatic cancers","volume":"21","author":"Ye","year":"2026","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0870","doi-asserted-by":"crossref","DOI":"10.1186\/s13020-023-00764-2","article-title":"Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment","volume":"18","author":"Huang","year":"2023","journal-title":"Chin. Med."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0875","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1039\/D3ME00151B","article-title":"Machine learning prediction of self-assembly and analysis of molecular structure dependence on the critical packing parameter","volume":"9","author":"Ishiwatari","year":"2024","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.addr.2026.115973_bb0880","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jcis.2023.06.086","article-title":"Supramolecular self-assembly of robust, ultra-stable, and high-temperature-resistant viscoelastic worm-like micelles","volume":"649","author":"Cao","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"21","key":"10.1016\/j.addr.2026.115973_bb0885","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1039\/D3SC06803J","article-title":"DiffBindFR: an SE(3) equivariant network for flexible protein-ligand docking","volume":"15","author":"Zhu","year":"2024","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0890","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s42256-024-00792-z","article-title":"State-specific protein\u2013ligand complex structure prediction with a multiscale deep generative model","volume":"6","author":"Qiao","year":"2024","journal-title":"Nat. Mach. Intell."},{"issue":"1","key":"10.1016\/j.addr.2026.115973_bb0895","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1038\/s41467-024-54440-6","article-title":"Interformer: an interaction-aware model for protein-ligand docking and affinity prediction","volume":"15","author":"Lai","year":"2024","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.addr.2026.115973_bb0900","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1158\/0008-5472.CAN-21-0952","article-title":"Improving tumor penetration of antibodies and antibody-drug conjugates: taking away the barriers for Trojan horses","volume":"81","author":"van Dongen","year":"2021","journal-title":"Cancer Res."},{"issue":"32","key":"10.1016\/j.addr.2026.115973_bb0905","doi-asserted-by":"crossref","first-page":"20861","DOI":"10.1021\/acsnano.4c02380","article-title":"Delivery strategy to enhance the therapeutic efficacy of liver fibrosis via nanoparticle drug delivery systems","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"issue":"46","key":"10.1016\/j.addr.2026.115973_bb0910","doi-asserted-by":"crossref","first-page":"32045","DOI":"10.1021\/acsnano.4c10381","article-title":"Extracellular matrix limits nanoparticle diffusion and cellular uptake in a tissue-specific manner","volume":"18","author":"Cahn","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115973_bb0915","article-title":"Hypoxia-adaptive penetration enhanced nanomedicine regulating cell\u2013internalization ability enabling the uniform distribution within tumors","volume":"505","author":"Liu","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"11","key":"10.1016\/j.addr.2026.115973_bb0920","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2026.115973_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115862","article-title":"Towards clinical translation of nanomedicines: formulation scale-up and model systems","volume":"234","author":"Kelly","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"19","key":"10.1016\/j.addr.2026.115973_bb0930","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180310","article-title":"The senescence-associated secretome of hedgehog-deficient hepatocytes drives MASLD progression","volume":"134","author":"Jun","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0935","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.gastro.2024.06.007","article-title":"Targeting 5-Hydroxytryptamine receptor 1A in the portal vein to decrease portal hypertension","volume":"167","author":"Zhu","year":"2024","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0940","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/0008-5472.CAN-14-1356","article-title":"p21 ablation in liver enhances DNA damage, cholestasis, and carcinogenesis","volume":"75","author":"Ehedego","year":"2015","journal-title":"Cancer Res."},{"issue":"16","key":"10.1016\/j.addr.2026.115973_bb0945","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.addr.2026.115973_bb0950","article-title":"Fatty acid oxidation-glycolysis metabolic transition affects ECM homeostasis in silica-induced pulmonary fibrosis","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"5","key":"10.1016\/j.addr.2026.115973_bb0955","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.addr.2026.115973_bb0960","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00161-2019","article-title":"Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases","volume":"54","author":"Wollin","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.addr.2026.115973_bb0965","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.addr.2026.115973_bb0970","first-page":"631","article-title":"Pegozafermin for NASH and fibrosis: phase IIb results","volume":"20","author":"Kotsiliti","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.addr.2026.115973_bb0975","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/acs.molpharmaceut.5c01175","article-title":"CD44-targeted pH-responsive Nanoenzyme-liposome complexes co-delivering ceria Nanozymes and Cryptotanshinone to alleviate liver fibrosis","volume":"23","author":"Liu","year":"2026","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.addr.2026.115973_bb0980","doi-asserted-by":"crossref","DOI":"10.1007\/s42114-025-01411-0","article-title":"Ultrasound-activated dual-nanozyme platform for targeted ROS scavenging and NO delivery in liver fibrosis therapy","volume":"8","author":"Yin","year":"2025","journal-title":"Adv. Compos. Hybrid Mater."},{"issue":"9","key":"10.1016\/j.addr.2026.115973_bb0985","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1021\/acsbiomaterials.5c00611","article-title":"Ultrasound-assisted targeted therapy for liver fibrosis using rosiglitazone-loaded lipid nanoparticles functionalized with RGD peptides","volume":"11","author":"Sun","year":"2025","journal-title":"ACS Biomater. Sci. Eng."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:58:03Z","timestamp":1790398683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26002073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":197,"alternative-id":["S0169409X26002073"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115973","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosis: Bridging fundamental mechanisms to precision medicine via advanced therapeutics","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115973"}}